
Akero Therapeutics, Inc.
AKRONASDAQ
USReal-Time Price
$54.65USD
0.00 (0.00%)Today
BTI Score
BASIC required or higher
View pricingBTI Fair Market Cap
$1.11B
+306.73% vs fair
Biotechnology
High Risk
Akero Therapeutics, Inc. (AKRO) Forecast & Price Targets
Review available Akero Therapeutics, Inc. (AKRO) analyst price targets and compare them with earnings and valuation. Analyst targets are separate from BTI scores; missing data is marked unavailable.
AKRO stock forecast and analyst price targets
Analyst price targets estimate possible future share prices. They are separate from BTI scores and fair-value models. The highest and lowest targets describe the provider's range, not the probability of a bull or bear scenario.
| Measure | Target (USD) | Difference from available quote |
|---|---|---|
| Highest analyst target | 56.00 | +2.5% |
| Consensus analyst target | 48.40 | -11.4% |
| Lowest analyst target | 38.00 | -30.5% |
The comparison uses the available quote, which may be delayed. It is not an expected return over a specified period.
How should I evaluate the AKRO forecast?
Compare the targets with reported earnings, cash flow, valuation assumptions and company risks. A price target alone does not determine whether an investment is suitable.


